Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Vivus to resubmit Qnexa NDA
With this plan, the company expects to seek approval for an initial indication that includes obese men and women of non-child bearing potential. The company intends to refile
With this plan, the company expects to seek approval for an initial indication that includes obese men and women of non-child bearing potential. The company intends to refile
The acquisition allows VBI to develop its own VLP-based vaccines by leveraging its suite of thermostable vaccine formulation technologies. The terms of the deal were not disclosed. VBI
Hyalgan is an injectable treatment for knee pain associated with osteoarthritis when simple painkillers or exercise and physical therapy are not enough. Following the transfer of the rights,
The additional funding is expected to support Cellerant’s CLT-008 development strategy to expand its current clinical trials, process development and manufacturing activities and to fund additional nonclinical studies
The agreement allows Verde to develop products which are designed to adsorb and inactivate the active ingredients in pills, tablets, capsules and topical patches, in a convenient and
Initially, Teva is expected to invest around $7.5m in CDI under which CDI will be responsible to develop an antiviral drug targeting the polymerase enzyme of the Hepatitis
NowClinic offers Rite Aid customers real-time access to convenient medical care, information and resources from doctors and OptumHealth nurses. With this new application, the customers of Rite Aid
Levetiracetam Extended-Release Tablets are the generic version of Keppra XR of UCB. Keppra is an anti-epileptic drug which is indicated for the treatment of partial onset seizures in
Qualitest has recalled Cyclafem 7/7/7, Cyclafem 1/35, Emoquette, Gildess FE 1.5/30, Gildess FE 1/20, Orsythia, Previfem and Tri-Previfem. In the packet, where select blisters were rotated 180 degrees
Under the deal, the companies will establish a learning facility – ‘McLaren GSK Centre for Applied Performance’ – to develop UK engineering skills and processes. Employees from both